Current Opinion in Oncology

Article	Citations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	63
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	43
Treatments and challenges in advanced prostate cancer	42
Role of PSMA PET/CT in imaging and management of prostate cancer	36
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	30
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	27
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	24
Editorial introductions	23
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	21
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	21
Psycho-oncology interventions focusing on fatigue and sleep disturbances	20
Harnessing dendritic cells for innovative therapeutic cancer vaccines	19
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	19
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	18
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	17
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	17
Indications and technique of minimally invasive surgery in early-stage cervical cancer	15
Biomarkers and immunotherapy: where are we?	15
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	14
Editorial introductions	14
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	13
Safety of assisted reproductive techniques in gynecological cancer patients	13
New hopes in relapsed refractory primary central nervous system lymphoma	13
Editorial introductions	13
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	12

Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	12
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	12
How to prevent human papillomavirus-related oropharyngeal cancer?	12
Editorial introductions	11
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	11
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	11
Immunomodulation for hepatocellular carcinoma therapy: current challenges	11
Recent advances in precision medicine for acute myeloid leukemia	11
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	11
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	11
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	11
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	11
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	10
Lung cancer screening in never smokers	10
Liquid biopsy in brain tumors: moving on, slowly	10
Editorial: Lung cancer: continuous progress in diagnosis and treatment	10
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	10
Circulating tumor DNA in breast cancer: a biomarker for patient selection	10
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	10
Editorial introductions	9
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	9
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	9
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	9
A new comprehensive and stratified concept for supportive care in cancer patients	8
The role of genetic testing in prostate cancer screening, diagnosis, and treatment	8
Editorial introductions	8
Pathology and new insights in central nervous system lymphomas	8
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	8
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	8
The changing landscape for patients with relapsed/refractory acute myeloid leukaemia	8
The 5T's of health disparities in multiple myeloma in Latin America	8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	8
Machine learning applications and challenges in graft-versus-host disease: a scoping review	8
Desmoid tumors: who, when and how to treat?	8
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
Potential application of artificial intelligence in cancer therapy	7
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	7
Editorial introductions	7
Editorial introductions	7
Pathologic diagnosis of lung cancer – recent developments	7
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	7
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	7
Mind the target: programmed death ligand 1 in oesophagogastric cancers	7
How to support parenting in patients with cancer and co-parents? From research to practice	7
Preclinical glioma models in neuro-oncology: enhancing translational research	7
Editorial introductions	7
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6

Cellular therapies in sarcoma and other solid tumors	6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
HIV-related lymphomas	6
Immunotherapies in non-metastatic gastrointestinal cancers	6
Editorial introductions	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	6
Question prompt lists to improve communication between cancer patients and healthcare professionals	6
Achievements of international rare cancers networks and consortia in the neuro-oncology field	6
Breast surgery after neoadjuvant therapy	6
Targeting cancer stem cell pathways for lung cancer therapy	6
Treatment of radiation-associated angiosarcoma	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
How to monitor the side effects of treatments in cancer patients	6
How to treat localized Hodgkin lymphoma?	6
Adjuvant and neoadjuvant approaches in pancreatic cancer	6
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	5
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?	5
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?	5
Perioperative immunotherapy in nonsmall cell lung cancer	5
Immunotherapy of sarcomas with modified T cells	5
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	5
Preoperative immunotherapy for head and neck cancers: state of art	5
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	5
Richter transformation: biological insights, diagnostic challenges and emerging therapies	5
Targeting exon 20 insertion mutations in lung cancer	5
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients	5
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	5
Polyamine metabolism in prostate cancer	5
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	5
Clinical management of brain tumors in pregnancy	5
Update on bi-specific monoclonal antibodies for blood cancers	5
Early Detection of Cancers in the Era of Precision Oncology	5
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	5
New trends in supportive care of head and neck cancers	5
Thymic malignancies: role of immunotherapy and novel approaches	5
Optimizing the prescription doses and tolerability of systemic therapy in head and neck cancer patients	4
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice	4
Editorial introductions	4
Molecular genotyping in medullary thyroid cancer	4
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	4
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	4
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	4
Evolving systemic management of urothelial cancers	4
Vascular complications in patients with brain tumors	4
Recent advances in immunotherapy for small cell lung cancer	4
Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?	4
Update of antibody–drug conjugates for hematological malignancies	4
Current opinion on laparoscopic surgery in gynecologic oncology: challenges and advances in elderly patients	4
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	4
New treatments for desmoid tumors	4
How to treat advanced Hodgkin lymphoma?	4
Future of sentinel node biopsy in ovarian cancer	4
Ovarian stimulation and oocyte cryopreservation in females with cancer	4
Editorial introductions	4
Precision medicine in extended adjuvant endocrine therapy for breast cancer	4
Editorial: Psychological interventions in oncology: advances and challenges	4
New strategies for the treatment of breast cancer with leptomeningeal metastasis	4
Minimally invasive surgery in advanced and recurrent ovarian cancer: current evidence and future directions	4
Treatment of small cell lung cancer: recent advances	3
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	3
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	3
Cancer-associated thrombosis: what is new?	3
New targeted treatments for advanced sarcomas	3
Advances in the treatment of light chain amyloidosis	3
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	3
Postneoadjuvant treatment for triple-negative breast cancer	3
Highlights of recent research focused on the treatment of advanced prostate cancer	3
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	3
Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies	3
First line treatments in primary central nervous system lymphomas in young patients	3
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?	3
Editorial introductions	3
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
Editorial Introductions	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
CIC-DUX4 sarcomas	3
Recent advances in allogeneic transplantation for acute myeloid leukemia	3

The role of next-generation sequencing in acute myeloid leukemia	3
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	3
Circulating tumor DNA in B cell lymphomas	3
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	3
Perioperative immunotherapy for nonsmall cell lung cancer	3
Use of staging for sex cord stromal tumours	3
Action against thoracic cancers: recent achievements and perspectives	3
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019–2021	3
Advances in testing for human papillomavirus-mediated head and neck cancer	3
Emerging therapies in Ewing sarcoma	3
Editorial: Advanced care planning	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	3
Challenges in the management of relapsed germ cell tumors	3
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	3
Sarculator: how to improve further prognostication of all sarcomas	3
Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept	3
Advance care planning in oncology: a scoping review and some recommendations	3
Recent advances in primary resistance mechanisms against immune checkpoint inhibitors	2
The role of autologous stem-cell transplantation in multiple myeloma in 2021	2
Artificial intelligence: opportunities in lung cancer	2
Treatment approaches for older Hodgkin lymphoma patients	2
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	2
Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA	2
Nanoparticle therapy for head and neck cancers	2
Chemotherapy-induced nausea and vomiting: can we do better?	2
New targeted therapies in liposarcoma: state of art and future perspectives	2
Postmastectomy radiotherapy: a review	2
Pediatric brain tumors as a developmental disease	2
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA	2
A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?	2
Editorial: Less is more in gynaecological oncology: paving the way for the future	2
Surrogate endpoints for HTA decisions of breast cancer drugs: utility and pitfalls	2
Management of epilepsy in brain tumor patients	2
Editorial introductions	2
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives	2
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma	2
Novel immunotherapeutic drugs for the treatment of lung cancer	2
The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma	2
Primary central nervous system lymphoma (PCNSL) in older patients	2
Implementation of sentinel node biopsy in high-risk endometrial cancer	2
Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?	2
Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria	2
Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer	2
Immuno-oncology in the daily practice	2
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities	2
Interventions for children of parents with cancer: an overview	2
Treatment of anaplastic gliomas: evidences and controversies	2
Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer	2
Active surveillance and emerging medical treatment options for desmoid: when and for whom?	2
Immune checkpoint inhibitors in elderly patients with lung cancer: evidence from phase 3 trials	2
Medical treatment of angiosarcomas	2
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	2